[Federal Register Volume 85, Number 33 (Wednesday, February 19, 2020)]
[Notices]
[Page 9474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03255]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Tick-Borne Disease Working Group
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As required by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting.
The meeting will be open to the public. For this meeting, the TBDWG
will be discussing and voting on recommendations for the 2020 TBDWG
Report to the HHS Secretary and Congress. Most of the recommendations
the TBDWG will consider are from the reports of eight TBDWG
subcommittees, which were created to examine critical topic areas
related to tick-borne diseases.
Additionally, the TBDWG created the Federal Inventory Subcommittee
and Public Comment Subcommittee. The Federal Inventory Subcommittee
will present an analysis of tick-borne disease research and funding
within federal agencies. The Public Comment subcommittee will provide
an update on key themes of the written comments to the TBDWG.
The 2020 report will address ongoing tick-borne disease research,
including research related to causes, prevention, treatment,
surveillance, diagnosis, diagnostics, duration of illness, and
intervention for individuals with tick-borne diseases; advances made
pursuant to such research; federal activities related to tick-borne
diseases; and gaps in tick-borne disease research.
DATES: The meeting will be held on March 3-4, 2020, from 9:00 a.m. to
5:00 p.m. ET (times are tentative and subject to change). The confirmed
times and agenda items for the meeting will be posted on the website
for the TBDWG at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-3-3/index.html when this information
becomes available.
ADDRESSES: The meeting will be held at The College of Physicians of
Philadelphia, 19 S 22nd St. Philadelphia, PA 19103. Members of the
public may also attend the meeting via webcast. Instructions for
attending via webcast will be posted about one week prior to the
meeting at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-3-3/index.html.
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Mary E. Switzer Building, 330 C Street SW,
Suite L600, Washington, DC 20024. Email: [email protected];
Phone: 202-795-7608.
SUPPLEMENTARY INFORMATION: In-person attendance at the meeting is
limited to space available; therefore, preregistration for public
members is advisable and can be accomplished by registering at https://www.eventbrite.com/e/tick-borne-disease-working-group-meeting-march-3-4-2020-meeting-12-tickets-90354618095. On the day of the meeting,
seating will be provided first to persons who have preregistered.
People who have not preregistered will be accommodated on a first come,
first served basis if additional seats are still available 10 minutes
before the meeting starts.
The public will have an opportunity to present their views orally
to the TBDWG during the meeting's public comment session or by
submitting a written public comment. Comments should be pertinent to
the meeting discussion. Persons who wish to provide verbal or written
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-3-3/index.html and
respond by midnight Thursday, February 20, 2020, ET. Verbal comments
will be limited to three minutes each to accommodate as many speakers
as possible during the two 30 minute sessions. Written public comments
will be accessible to the public on the TBDWG web page prior to the
meeting.
Background and Authority: The Tick-Borne Disease Working Group was
established on August 10, 2017, in accordance with Section 2062 of the
21st Century Cures Act, and the Federal Advisory Committee Act, 5
U.S.C. App., as amended, to provide expertise and review federal
efforts related to all tick-borne diseases, to help ensure interagency
coordination and minimize overlap, and to examine research priorities.
The TBDWG is required to submit a report to the HHS Secretary and
Congress on their findings and any recommendations for the federal
response to tick-borne disease every two years.
James Berger,
Designated Federal Officer, Tick-Borne Disease Working Group Office of
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2020-03255 Filed 2-18-20; 8:45 am]
BILLING CODE 4150-28-P